Clinical Trials Logo

Adenovirus Infections clinical trials

View clinical trials related to Adenovirus Infections.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04706923 Recruiting - Clinical trials for Cytomegalovirus Infection

A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection

ATHENA
Start date: August 16, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the safety and tolerability of intravenous (IV) brincidofovir (BCV; SyB V-1901) 0.2 mg/kg, 0.3 mg/kg or 0.4 mg/kg dosed twice weekly (BIW) or 0.4 mg/kg dosed once weekly (QW) for 4 weeks in subjects with AdV, and IV BCV in subjects with CMV